Previous close | 0.0000 |
Open | 0.0000 |
Bid | 0.0000 x 0 |
Ask | 0.0000 x 0 |
Day's range | 0.0000 - 0.0000 |
52-week range | |
Volume | |
Avg. volume | N/A |
Market cap | 1.097M |
Beta (5Y monthly) | 0.56 |
PE ratio (TTM) | N/A |
EPS (TTM) | -0.2490 |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
VALENCE, France, July 20, 2023--Regulatory News: Amplitude Surgical (ISIN: FR0012789667, Mnemo: AMPLI, PEA-PME eligible), a leading French player on the surgical technology market for lower-limb orthopedics, announces its consolidated sales for fiscal year 2022-23.
VALENCE, France, June 29, 2023--Regulatory News: Amplitude Surgical (ISIN: FR0012789667, Ticker: AMPLI, eligible for PEA-PME savings plans), a leading French player on the surgical technology market for lower-limb orthopedics, announces the closing of the sale of the entire Novastep business, specializing in extremity surgery (feet and ankles) to Enovis Corporation.
VALENCE, France, April 20, 2023--Regulatory News: Amplitude Surgical (ISIN: FR0012789667, Ticker: AMPLI, eligible for PEA-PME plans) (Paris:AMPLI), a leading French player on the surgical technology market for lower-limb orthopedics, announces its sales for the third quarter and first 9 months of its 2022-23 financial year.